Joseph R Podojil

10PUBLICATIONS
50CO-AUTHORS
Innate immunityMolecular targetsGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 02, 2026
STING/type I interferon pathway is required for antigen-containing PLGA nanoparticle- and apoptotic cell-induced CD4+ T cell tolerance.

Joseph R Podojil, Andrew C Cogswell, Tobias Neef

|Oct 05, 2022
Immune activation is essential for the antitumor activity of EZH2 inhibition in urothelial carcinoma.

Andrea Piunti, Khyati Meghani, Yanni Yu

|Jul 09, 2022
Repurposing the cardiac glycoside digoxin to stimulate myelin regeneration in chemically-induced and immune-mediated mouse models of multiple sclerosis.

Haley E Titus, Huan Xu, Andrew P Robinson

|Jun 20, 2022
Tolerogenic Immune-Modifying Nanoparticles Encapsulating Multiple Recombinant Pancreatic β Cell Proteins Prevent Onset and Progression of Type 1 Diabetes in Nonobese Diabetic Mice.

Joseph R Podojil, Samantha Genardi, Ming-Yi Chiang

|Jun 18, 2020
Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma.

Erik Ladomersky, Lijie Zhai, Kristen L Lauing

|Jun 15, 2018
B7-H4 Modulates Regulatory CD4+ T Cell Induction and Function via Ligation of a Semaphorin 3a/Plexin A4/Neuropilin-1 Complex.

Joseph R Podojil, Ming-Yi Chiang, Igal Ifergan

Pageof 2

Frequent Collaborators

7 joint publications

Stephen D Miller

2 joint publications

Christopher T Harp

2 joint publications

Joshua J Meeks

2 joint publications

Damiano Fantini